Evidence map›Paper›PMID 33797341›Full record

ArticlePathogens and global health

Circulation of dengue serotype 1 viruses during the 2019 outbreak in Dar es Salaam, Tanzania.

Gaspary O Mwanyika, Leonard E G Mboera, Sima Rugarabamu, Mariam Makange, Calvin Sindato, Julius J Lutwama, Janusz T Paweska, Gerald Misinzo

Open access · bronzeAbstract read
In one paragraph

Article in Pathogens and global health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Gaspary O MwanyikaSACIDS Africa Centre of Excellence for Infectious Diseases, Sokoine University of Agriculture, Morogoro, Tanzania.ORCID 0000-0001-5549-8393
Leonard E G MboeraSACIDS Africa Centre of Excellence for Infectious Diseases, Sokoine University of Agriculture, Morogoro, Tanzania.ORCID 0000-0001-5746-3776
Sima RugarabamuSACIDS Africa Centre of Excellence for Infectious Diseases, Sokoine University of Agriculture, Morogoro, Tanzania.ORCID 0000-0003-1473-3750
Mariam MakangeSACIDS Africa Centre of Excellence for Infectious Diseases, Sokoine University of Agriculture, Morogoro, Tanzania.
Calvin SindatoSACIDS Africa Centre of Excellence for Infectious Diseases, Sokoine University of Agriculture, Morogoro, Tanzania.ORCID 0000-0003-3040-165X
Julius J LutwamaDepartment of Arbovirology, Emerging and Re-emerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda.
Janusz T PaweskaNational Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.ORCID 0000-0001-8776-7519
Gerald MisinzoSACIDS Africa Centre of Excellence for Infectious Diseases, Sokoine University of Agriculture, Morogoro, Tanzania.ORCID 0000-0003-1827-6403
Southern African Centre for Infectious Disease Surveillance · TZMbeya University of Science and Technology · TZMuhimbili University of Health and Allied Sciences · TZNational Health Laboratory Service · ZAUganda Virus Research Institute · UG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dengue is an important mosquito-borne viral disease in humans in tropical and subtropical countries. In 2019, a total of 6917 dengue cases were reported in Tanzania based on serological analysis. The aim of this study was to confirm the presence of dengue virus (DENV) and conduct its genetic characterization. A total of 191 serum samples were collected from the outpatients seeking care from health facilities in Kinondoni and Ilala districts between March and May 2019. All the samples were initially tested for the presence of non-structural protein 1 and anti-DENV immunoglobulin G (IgG) and IgM using a commercial OnSite Duo Dengue Ag-IgG/IgM rapid test. Of the 191 sera, 110 (57.6%) were DENV seropositive. The presence of DENV ribonucleic acid was confirmed in 18.2% of the seropositive sera by reverse transcription polymerase chain reaction (RT-PCR). The RT-PCR products were cleaned and partial sequences of DENV polyprotein gene determined using dideoxynucleotide cycle sequencing followed by phylogenetic analysis. We present the occurrence of DENV serotype 1 (DENV-1) during the 2019 outbreak in Tanzania. The DENV-1 strains reported in the present study are highly identical and cluster with Asian DENV-1 strains indicating the possibility of intercontinental spread of DENV through globalization. We advocate for the need for molecular surveillance of dengue viruses during outbreaks to provide rapid evidence of the disease to guide public health interventions.

Indexed as

DengueDengue VirusAnimalsDisease OutbreaksHumansPhylogenySerogroupTanzaniaDengue virusoutbreakserotype 1Tanzania

Identifiers

PMID33797341
PMCPMC8635661
OpenAlexW3146139568

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.